Insider Selling: Anterix (NASDAQ:ATEX) Insider Sells 23,439 Shares of Stock

Key Points

  • Anterix insider Christopher Guttman-McCabe sold 23,439 shares at an average price of $92.36, generating $2.16 million. The sale covered tax-withholding obligations tied to vested equity awards and reduced his direct holdings by 34.31% to 44,876 shares.
  • Anterix shares opened at $94.67, with a market capitalization of approximately $1.86 billion and a 52-week range of $17.58 to $113.00. The company recently reported quarterly EPS of $0.01, beating the consensus estimate of a $0.43 loss, while revenue of $1.96 million was slightly below forecasts.
  • Analyst sentiment remains mixed but leans positive: Anterix has a consensus rating of “Moderate Buy” and an average price target of $120, though recent ratings included upgrades, downgrades and a neutral call. Institutional investors own approximately 87.67% of the company.

Anterix Inc. (NASDAQ:ATEX - Get Free Report) insider Christopher Guttman-Mccabe sold 23,439 shares of the company's stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $92.36, for a total transaction of $2,164,826.04. Following the completion of the sale, the insider directly owned 44,876 shares of the company's stock, valued at $4,144,747.36. This trade represents a 34.31% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Christopher Guttman-Mccabe also recently made the following trade(s):

  • On Monday, June 15th, Christopher Guttman-Mccabe sold 91,437 shares of Anterix stock. The stock was sold at an average price of $82.46, for a total transaction of $7,539,895.02.

Anterix Stock Up 0.5%

Shares of NASDAQ:ATEX opened at $94.67 on Friday. The stock has a market cap of $1.86 billion, a PE ratio of 27.05 and a beta of 0.85. The company's fifty day moving average is $95.51 and its 200 day moving average is $64.48. Anterix Inc. has a 52 week low of $17.58 and a 52 week high of $113.00.




Anterix (NASDAQ:ATEX - Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.43) by $0.44. The business had revenue of $1.96 million during the quarter, compared to analyst estimates of $2.00 million. Anterix had a net margin of 933.03% and a negative return on equity of 10.65%. Sell-side analysts anticipate that Anterix Inc. will post -2 EPS for the current year.

Wall Street Analyst Weigh In

ATEX has been the topic of several recent research reports. B. Riley Financial lowered Anterix from a "buy" rating to a "neutral" rating and raised their price target for the stock from $44.00 to $69.00 in a research report on Thursday, June 4th. Clear Str upgraded Anterix to a "strong-buy" rating in a research report on Monday, July 27th. Weiss Ratings raised Anterix from a "hold (c)" rating to a "hold (c+)" rating in a research note on Friday, June 26th. DA Davidson set a $161.00 target price on shares of Anterix in a report on Friday, August 21st. Finally, Wall Street Zen downgraded shares of Anterix from a "hold" rating to a "sell" rating in a research note on Saturday, August 15th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Anterix currently has an average rating of "Moderate Buy" and a consensus price target of $120.00.

Read Our Latest Stock Report on ATEX

Institutional Trading of Anterix

A number of institutional investors have recently modified their holdings of the company. Parallel Advisors LLC grew its stake in shares of Anterix by 63.7% in the first quarter. Parallel Advisors LLC now owns 933 shares of the company's stock worth $36,000 after purchasing an additional 363 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in Anterix by 0.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 138,677 shares of the company's stock valued at $3,027,000 after purchasing an additional 599 shares during the last quarter. Russell Investments Group Ltd. raised its position in Anterix by 12.4% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,760 shares of the company's stock valued at $148,000 after purchasing an additional 637 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Anterix by 17.0% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,084 shares of the company's stock worth $182,000 after buying an additional 1,029 shares during the period. Finally, Tower Research Capital LLC TRC lifted its holdings in Anterix by 299.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,645 shares of the company's stock worth $42,000 after buying an additional 1,233 shares during the period. 87.67% of the stock is currently owned by hedge funds and other institutional investors.

Anterix Company Profile

(Get Free Report)

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.

Read More

Insider Buying and Selling by Quarter for Anterix (NASDAQ:ATEX)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Anterix?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Anterix and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles